Rapidly Progressive Fatal Pneumococcal Meningitis in a Fully Immunized Child With a History of Facial Bone Fractures

Brianna N Stanley1, Haya B Rizvi2, Hanna S Sahhar3,1

  • 1Pediatrics, Edward Via College of Osteopathic Medicine, Spartanburg, USA.

Cureus
|May 29, 2024
PubMed

Insights

A fully immunized child developed severe pneumococcal meningitis despite vaccination. This case highlights rapid disease progression and complications following facial trauma, emphasizing the need for vigilance.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Neurology

Background:

  • Meningitis, inflammation of the meninges, presents with diverse symptoms including fever, headache, and neck stiffness.
  • Bacterial meningitis, often caused by Streptococcus pneumoniae, remains a concern despite vaccine availability, with non-vaccine serotypes posing a risk.
  • Pneumococcal conjugate and polysaccharide vaccines have reduced infections, but invasive pneumococcal disease still occurs.

Observation:

  • A six-year-old male, fully immunized, presented with classic meningitis signs and symptoms.
  • The patient experienced rapid disease progression within 12 hours, including altered physical exam findings and respiratory depression.
  • A history of extensive traumatic facial bone fractures six months prior was noted.

Findings:

  • The case involved rapidly progressing pneumococcal meningitis in a fully immunized child.
  • Septic thrombophlebitis and subsequent brain herniation were suspected complications.
  • The presentation was unique, occurring six months after severe facial trauma.

Implications:

  • This case underscores the possibility of severe pneumococcal meningitis even in fully immunized individuals.
  • It highlights potential complications, such as septic thrombophlebitis and brain herniation, following severe facial trauma.
  • Further investigation into the interplay between trauma, immunization status, and invasive pneumococcal infections is warranted.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
221
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
202
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
322
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
258
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
234